Daiichi Sankyo names Ken Keller as President, US Commercial

Japanese drugmaker Daiichi Sankyo has announced that Ken Keller will join the company as President of its Commercial operations in the United States starting May 1, 2014.

In his role, Mr Keller will be responsible for leading marketing, sales, medical affairs and supply chain operations for Daiichi Sankyo in the US.

“We are very pleased to welcome Ken Keller into the Daiichi Sankyo family,” said Joji Nakayama, President and CEO of Daiichi Sankyo Co, the parent company of the Daiichi Sankyo Group.  “Ken brings with him more than 25 years of pharmaceutical experience, with career highlights including building a $3 billion business unit as well as leading commercialization for four of the world's top selling biologic medicines.  His broad experience and proven success will be a tremendous asset to Daiichi Sankyo.”